Principal Investigator
Camillo Ricordi
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20230057
Clinical Trial Summary
A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of VX-264 in Subjects With Type 1 Diabetes Mellitus
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other